USA: Mount Sinai PACS clinic and Dr David Putrino

Discussion in 'USA clinics and doctors' started by Kalliope, Jul 21, 2021.

  1. EndME

    EndME Senior Member (Voting Rights)

    Messages:
    1,369
    A long Twitter thread by David Putrino, with some possibly valuable points but also many very worrying points not based on current evidence with statements such as "we know that many people with #LongCOVID and chronic #lyme are sick because of persistent pathogens", "Similarly, for those with IACCs, the triggering pathogen HAS to matter", "Similarly, we know that many pw #LongCOVID, chronic #lyme and #MECFS have co-infections. In fact, some evidence even exists showing that some persistent pathogens may not even be that bad until they’re running with the wrong crowd, so even though your most recent infection pushed you into the chronic disease state, it may well be the combination of persistent pathogens that is the problem", "scientists who are “IACC-literate” have done to develop meaningful strategies to manage MCAS, mitochondrial dysfunction, POTS, chronic pain, cognitive impairment, endothelial dysfunction and other symptoms have been game-changing for many of our patients."

    https://twitter.com/user/status/1811017747662241855
     
  2. Murph

    Murph Senior Member (Voting Rights)

    Messages:
    187
    I enjoyed the thread. There's definitely an emerging consensus among certain scientists in the US that there is a persistent pathogen (or pathogens). Do I think that's 100% likely to be true? No, the hit-and-run hypothesis is still plausible. Do I think it's a good clue worth digging into? 100% yes.

    And do I accept that a sort of certainty is incredibly energising for scientists? Yep. Science's great leaps seem to be driven by maniacs with a bee in their bonnet who turn out, by chance, to be right. I really want them to dig into tissues and subcellular organelles and look for latent viruses, and if the only way they do that is if they're sure they'll find it, fine!

    These guys who are confident can win funding, and so long as the community can look at their work, ex-post, and assess it critically / replicate it, I think this is a good and normal part of science.
     
    bobbler, Lou B Lou, EzzieD and 2 others like this.
  3. Sean

    Sean Moderator Staff Member

    Messages:
    8,567
    Location:
    Australia
    Sometimes you just have to throw a bunch of half-plausible ideas at the wall and see what empirically sticks.
     
    EzzieD, ukxmrv and Peter Trewhitt like this.
  4. Peter Trewhitt

    Peter Trewhitt Senior Member (Voting Rights)

    Messages:
    4,546
    At times in science we see bright but over confident individuals produce a theory that is plausible on the basis of some evidence, that changes the direction of research, then other have to put their life into demonstrating the first person was wrong or at best oversimplifying.

    It is one thing to do this in the physical sciences but potentially dangerous in medicine. People with ME have particularly suffered from individuals who are bright but totally unable to stand back and objectively evaluate their own work, this becomes dogma or medicine by belief.
     
    Utsikt, alktipping, Murph and 11 others like this.
  5. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    16,181
    Location:
    London, UK
    Except that these people are banging on about tired old ideas that all of us have looked at and seen the shortcomings of. I don't see any new ideas in any of these twitter threads - I see sheep wandering off to nowhere in particular and taking large numbers of dollars with them.

    Science actually moves forward by guy's with a bee in their bonnet that is different from the sheep and is based on clear thinking, not luck, by and large.
     
    Utsikt, bobbler, Ariel and 9 others like this.
  6. Murph

    Murph Senior Member (Voting Rights)

    Messages:
    187
    So you think there's sufficient empirical evidence to disprove the concept of viral latency / viral reservoirs in tissue? What about John Chia's work?
     
    Lou B Lou and Peter Trewhitt like this.
  7. EndME

    EndME Senior Member (Voting Rights)

    Messages:
    1,369
    You didn't address me, but since I stated I was "worried" let me clarify why.

    I don't think so and I also think more work on this front is very much warranted. However, is anybody really "digging into it" as you state? I only see people with a shovel in their hand pointing at how many people are also holding shovels, stating the hole has already been dug.

    As you say "What about John Chia's work?". Why is no one doing a quick replication study, if that work bears relevance?

    I have no problem with a field being convinced of something even when the evidence isn't there yet. I only see a problem when that leads to a dogmatic belief that doesn't improve the research that field is doing.

    I still have hope that, that changes and it might be far to premature to make any assessments yet, but I do hope that the next studies of viral persistence that I read don't all have the same very basic shortcomings as they did in the past 4 years (lack of controls, lack of controlling for reinfection, lack of quantifying symptomology, lack of quantifiying data according to LC duration and last known Covid infection etc). I don't want to see more research that ends up invalidating itself due to poor methodology.

    This doesn't necessarily apply to Putrino as he hasn't published too much research on viral persistence. So there's hope that when he does, his research is of higher quality than what we have seen thus far being produced by other teams.
     
    bobbler, Murph, Sean and 4 others like this.
  8. Mij

    Mij Senior Member (Voting Rights)

    Messages:
    9,972
    shak8, Sean, JellyBabyKid and 4 others like this.
  9. Mij

    Mij Senior Member (Voting Rights)

    Messages:
    9,972
    work my team has done and the discoveries we have made over the last four years. We did it without a cent of NIH funding. Our 6+ clinical trials we will complete over the next 3+ years will be completed without a cent of NIH funding. We won’t quit on you and there are some
    https://twitter.com/user/status/1854172900300886437
     
  10. Mij

    Mij Senior Member (Voting Rights)

    Messages:
    9,972
    absolute heroes out there putting smart money behind IACC research without the involvement of the NIH and they are the entities, not the NIH, that have created the most impact in the field to date. So that’s the message: look after yourself today, because we need you.
    https://twitter.com/user/status/1854172902385766640
     
    Lou B Lou, shak8, bobbler and 4 others like this.
  11. Dakota15

    Dakota15 Senior Member (Voting Rights)

    Messages:
    951
    Last edited by a moderator: Jan 3, 2025
  12. bicentennial

    bicentennial Senior Member (Voting Rights)

    Messages:
    190
    STUDY NOTES

    101: Eligibility

    - if reading the You-Tube transcript correctly - padded out with study obs:


    The eligible definition of Long Covid was updated by some or all stakeholders. This new, breathtaking, “broad” cohort-delineation may be problematical and it may prevail. It was staked out as “inclusive” so that all in need can or may access those resources crucial for any kind of care -diagnosis, service etc - if the need is eligible

    Seems the neural stupefaction could be excluded unless there are other signs of LC - always did lose 2 or 3 IQ points per infection - so K. I. S. S, its just a quotient. Long Covid had such variegating definitions that amulgamated stakeholders had to draw the line of eligibility – simply re-defining it as:

    - A chronic disease state (yes, verbatim, diseased), persistent for the foreseeable (as yet without prognostic indication)
    - Any decline in health since their Covid infection (but see exclusion)
    - Sorry, make that their confirmed or probable case of acute Covid
    - Include any organ damage from acute stage oi oi oi that’s not due to LC so its got different epi-generation so….. then … ...
    - Exclude neural damage acquired in acute stage (unless with a Long Covid on top) ???

    If confirmed or probable…. If it was acute without symptoms then acute was just the term for pre-chronic. Or is it only acute if symptomatic? Must symptoms be confirmed or even recorded as reported, and who got tested these days. We were not wimps, we were not snowflakes, we were tough cookies (see 104)

    These stakeholders provided their experts under auspice of some National Academies (of Science, Engineering and Medicine), so I guess its not official USA Govt. Policy, or maybe their Colleges (not being Royal, yet) are also Trade Associations, too. Its legalistic because holding a stake often means no-one around can or will provide for the more costly impoverished cripples, unless some stakeholder can be legally required to, even by mission

    The costs of life’s essential commodities are or are not met, there being always enough to go round: air, space, land water, shelter, fuel, food, water, kit, facilities, education and training, health and community care, transport, comms, euthanasia and / or nursing, even d.i.y nursing costs extra

    This update also allows for some (but not all) of the reasonable doubt in such very civil cases
    - Probability put under burden of proof in Civil Law, not as like as not but more likely than not
    - - hearsay allowed

    Confirmation is put under burden of proof in Criminal Law long gone beyond reasonable doubt
    - - hearsay not allowed
    - - - Um there might even be precedent set by reckless or deliberate cognisant transmission (e.g. H.I.V, e.g. Hepatitis C transfusion)

    ee1b1845937430aa.jpg
     
    Peter Trewhitt likes this.
  13. bicentennial

    bicentennial Senior Member (Voting Rights)

    Messages:
    190
    - Transcriber: Matheus Miranda

    so is it not always automated then?
    - Reviewer: Massa Krayem
    even better ... must be a professional outfit

    My study notes - if reading their You-Tube Transcript correctly - padded out with study obs:

    Seems the neural stupefaction could be excluded unless there are other signs of LC

    - always lose 2 - 3 IQ points per infection, so K. I. S. S, its just a quotient
    - see study note 101 below, sorry, above
     
    Peter Trewhitt likes this.
  14. Kalliope

    Kalliope Senior Member (Voting Rights)

    Messages:
    6,736
    Location:
    Norway
    Podcast Long Covid - The Answers
    Episode 27: Long COVID Research & Potential Treatments Part 1 ft Professor David Putrino

    From presentation:

    Dr. David Putrino highlights the complexity of Long COVID, emphasizing hormonal and neurological impacts. Research shows hormonal disruptions, including low cortisol, are common in some patients, influencing symptoms like fatigue. Gender-specific patterns reveal women often have low testosterone, while men show reduced estradiol, correlating with differing symptoms. Neurologically, Long COVID causes neuroinflammation and vagus nerve dysfunction, contributing to issues like cognitive impairment and POTS. Emerging treatments include medications, innovative devices like vagus nerve stimulators and magnetic resonance therapy, and procedures such as stellate ganglion blocks. These interventions, supported by ongoing research, offer hope for tailored therapies to address Long COVID’s diverse effects.


    https://longcovidtheanswers.com/e27-long-covid-research-treatments-david-putrino/
     
  15. Dakota15

    Dakota15 Senior Member (Voting Rights)

    Messages:
    951
    Some quotes from Putrino's talk above:

    DP: 'The next generation of research studies that we need to understand is when the virus persists & when pieces of the virus persist, so viral antigens..what damage is it doing?'

    DP: 'We should also be working in parallel to deploy and test interventions that may have a role in eradicating the virus from the body. So, to that end there are many broad-spectrum antiviral medications that are worthwhile in trialing..'

    DP: "We are hoping that low-dose rapamycin (which at a low dose is a very safe drug with very few adverse events) can be helpful in a subset of people with Long COVID who may be experiencing this immune dysregulation flavor that includes T-cell exhaustion..."

    "We're currently running a first in human clinical trial with a company called Humanity Neurotech that uses low field magnetic resonance therapy to reduce neuroinflammation. Their animal model data has been very compelling, showing that it can reduce the level of neuroinflammation being experienced in animals. Our first clinical trial in Long COVID is currently underway, looking at the result of the ability of this head-worn device."
     
  16. Hutan

    Hutan Moderator Staff Member

    Messages:
    31,021
    Location:
    Aotearoa New Zealand
    That's as dense a collection of unevidenced statements as I have seen for quite some time, even counting the output of the BPS proponents. I am disappointed (edit - actually, that's too mild. I read that feeling increasingly horrified). If the researchers we are relying on to find answers, no matter how well meaning, are starting with a whole lot of incorrect assumptions, the chance of progress is much lower.
     
    Last edited: Jan 4, 2025
    Utsikt, Deanne NZ, Sean and 7 others like this.
  17. EndME

    EndME Senior Member (Voting Rights)

    Messages:
    1,369
    At least they stopped discussing the biomarker breakthrough of cortisol. Oh wait, they haven't...
     
  18. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    2,285
    Spitting into the wind…
     
    Sean, alktipping and Peter Trewhitt like this.
  19. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    2,285
    https://bsky.app/profile/putrinolab.bsky.social/post/3lfvd7ciapc25

    Since my episode with the wonderful @longcovidanswer has been released highlighting viral persistence as a major driver of some #LongCOVID pathology, I’ve been asked repeatedly, “what should we do about it?” - totally fair question. Here is my proposed roadmap: 1/


    Thread by Putrino…I don’t know how to post these Bluesky things.

    (Thread not good IMO)

    Also on Twitter/X

    https://twitter.com/user/status/1880017536265384374
     
    Last edited: Jan 26, 2025
    EzzieD, Yann04, Trish and 1 other person like this.
  20. Hutan

    Hutan Moderator Staff Member

    Messages:
    31,021
    Location:
    Aotearoa New Zealand
    Putrino's twitter thread:


    First, let me point out that there are antiviral programs and drugs out there that people have been trying to mixed effects: e.g. Truvada, Maraviroc, Maraviroc + Statins, Valtrex, Valtrex + Celebrex, Paxlovid and various combos of these. This is NOT medical advice or urging 2/

    anyone to try these things without knowing your history, but more to say that people are trying them for persistence and the results are mixed. Similarly, there are many monoclonal products that may hold promise on their own and in combo with antivirals: evusheld, aerium, 3/

    regencov, etc…but monoclonals are much harder to access even if you self-pay and many have been shelved by the pharma companies (or the companies no longer exist) because they were designed to treat specific COVID strains that are no longer dominant - which also reminds us 4/

    that unless you’re trialing a more broad spectrum monoclonal for #LongCOVID you must be sure to trial one for the SARS-CoV-2 strain that triggered your LC. Finally, if you believe that persistence is occurring, but maybe it is occurring because your immune system is failing to 5/

    clear pathogens, then maybe immune modulating therapies may have a role, such as low dose rapamycin, which has been shown in other, non-LC trials to reduce T Cell exhaustion, enhance natural killer cell function and stabilize interferon signaling. There are many other targets 6/

    to think about in the world of persistence and even more feasible combinations to consider (watch out for a paper led by the amazing
    @microbeminded2
    on this topic in early Feb) and many of these options are available right now to patients who are able to afford to pay cash. 7/

    The reason cash is necessary is because these are “off-label” protocols, meaning that the FDA has not approved them for use under the #LongCOVID diagnosis and therefore insurers are not willing to cover the cost of the treatments. Furthermore, as I mentioned earlier: outcomes 8/

    for many of these therapies are all over the map. This is not because they’re bad targets, rather it is because the powers that be who have funded the last 50 years of infection-associated chronic condition (IACC) research have fumbled the bag so badly on persistence that we 9/

    still don’t have mainstream access to valid and reliable tools that can evaluate and differentiate responders to certain therapies over others on the basis of viral persistence and reactivated pathogens. What our #LongCOVID and IACC communities desperately need are precision 10/

    medicine approaches based on next-generation tests for persistent pathogens and subsequent targeted combo antiviral and monoclonal therapies (when persistence is detected). What we have is people paying large sums of money for therapies that have a chance of working but very 11/

    little certainty. Our team is endlessly fortunate to be able to work with some of the most advanced labs in the world who are working to validate why some research participants are responding to drug targets vs. not responding at all. This work is important because it will 12/

    allow us to secure FDA indications for different drugs and combos for which will then allow for insurance coverage and more accessible care. Thanks to the visionary work and leadership from
    @polybioRF
    - we aren’t alone in this mission: the Long COVID Research Consortium 13/

    continues to produce work that is shining a light on the pathobiology of #LongCOVID and all IACCs that will inform research and care for decades to come (and likely as new IACCs emerge - an unsettling thought but undeniable as we see H5N1 on the horizon). So. TLDR: what can 14/

    be done for persistence? Lots of good-faith options if you: can find doctors willing to prescribe Have resources for off-label drugs (also look at places like
    @costplusdrugs)
    Understand that you may have to try multiple things before something sticks and that isn’t 15/

    because persistence isn’t real, but because the science was stunted for many years by people denying it in favor of pet theories that psychologize and gaslight patients and now we need to catch up with other fields of precision medicine such as oncology. We have a lot of lost 16/

    time to make up for, and I want to assure everyone that my team is working around the clock to get answers out to the community and therapies approved. I hope this thread has helped to point at directions and research that may be helpful /end
     
    Sean, EzzieD, hibiscuswahine and 3 others like this.

Share This Page